Compound Detail
CHEMBL31634
BRIVUDINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL31634 |
| Name | BRIVUDINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | ODZBBRURCPAEIQ-PIXDULNESA-N |
| Active Moiety | CHEMBL4594370 |
18
Targets
241
Activities
3
Assay Types
1
PK Parameters
20
Publications
9
Known Names
3
Indications
Molecular Properties
333.1
MW (Da)
-0.46
ALogP
6
HBA
3
HBD
104.5
PSA (Ų)
0.69
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Pancreatic Neoplasms Virus Diseases Colorectal Neoplasms
ATC Classification
J05AB15
brivudine
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIVIRALS FOR SYSTEMIC USE
Activity Summary
EC50 216 meas. best 8.52
IC50 21 meas. best 9.0
Ki 4 meas. best 7.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HEL CHEMBL613888 | IC50 | 9.0 | 8.65 | 1.0 | 2 |
| HEL CHEMBL613888 | EC50 | 8.52 | 6.4863 | 3.0 | 8 |
| Human alphaherpesvirus 3 CHEMBL613132 | EC50 | 8.52 | 6.951 | 3.0 | 81 |
| Human alphaherpesvirus 1 CHEMBL377 | EC50 | 8.15 | 6.6039 | 7.0 | 49 |
| Human betaherpesvirus 5 CHEMBL371 | EC50 | 7.8 | 6.9367 | 16.0 | 3 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 7.72 | 5.6733 | 19.0 | 3 |
| Human alphaherpesvirus 2 CHEMBL370 | IC50 | 7.12 | 7.12 | 76.0 | 1 |
| Thymidine kinase, cytosolic CHEMBL2883 | Ki | 7.0 | 7.0 | 100.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 7.0 | 7.0 | 100.0 | 1 |
| HeLa CHEMBL399 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| Thymidine kinase CHEMBL1795127 | Ki | 6.62 | 6.62 | 240.0 | 1 |
| Thymidine kinase CHEMBL1820 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 6.46 | 6.34 | 350.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 5.89 | 5.89 | 1300.0 | 1 |
| Human alphaherpesvirus 1 CHEMBL377 | IC50 | 5.85 | 5.085 | 1400.0 | 2 |
| Vaccinia virus CHEMBL613493 | EC50 | 5.82 | 5.0788 | 1500.0 | 24 |
| L1210 CHEMBL386 | IC50 | 5.02 | 4.72 | 9600.0 | 2 |
| ADMET CHEMBL612558 | IC50 | 5.0 | 4.545 | 10000.0 | 2 |
| Mus musculus CHEMBL375 | Ki | 4.64 | 4.64 | 23000.0 | 1 |
| Human alphaherpesvirus 3 CHEMBL613132 | IC50 | 4.54 | 4.54 | 29000.0 | 1 |
| Human alphaherpesvirus 2 CHEMBL370 | EC50 | 4.54 | 4.2954 | 29000.0 | 13 |
| Felid alphaherpesvirus 1 CHEMBL612743 | EC50 | 4.52 | 4.52 | 30000.0 | 1 |
| Thymidine kinase CHEMBL1075062 | IC50 | 4.49 | 4.49 | 32300.0 | 1 |
| CCRF-CEM CHEMBL382 | IC50 | 4.0 | 4.0 | 100000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 254.6 | - | Chlorocebus sabaeus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 3005566 | 10.1021/jm00152a008 | E6SM | 40 |
| 8388474 | 10.1021/jm00057a003 | Mus musculus | 18 |
| 4067994 | 10.1021/jm00149a024 | Mus musculus | 13 |
| 2329561 | 10.1021/jm00167a019 | Mus musculus | 12 |
| - | 10.1016/0960-894X(95)00278-2 | HEL | 11 |
| 1652017 | 10.1021/jm00112a011 | E6SM | 11 |
| 7877148 | 10.1021/jm00005a010 | E6SM | 11 |
| 2547072 | 10.1021/jm00128a029 | Oryctolagus cuniculus | 11 |
| 2391680 | 10.1021/jm00171a009 | ADMET | 10 |
| 1324318 | 10.1021/jm00095a019 | ADMET | 10 |
| 9135038 | 10.1021/jm960770e | E6SM | 10 |
| 16000005 | 10.1021/jm050291s | HEL | 10 |
| 14584954 | 10.1021/jm030241s | Human alphaherpesvirus 3 | 10 |
| 2061920 | 10.1021/jm00110a003 | HEL | 9 |
| 2061920 | 10.1021/jm00110a003 | E6SM | 9 |
| 10411487 | 10.1021/jm991017z | HEL | 8 |
| 6300403 | 10.1021/jm00358a029 | Oryctolagus cuniculus | 8 |
| 11472207 | 10.1021/jm0108404 | E6SM | 7 |
| 1652017 | 10.1021/jm00112a011 | HEL | 7 |
| 7877148 | 10.1021/jm00005a010 | HEL | 7 |
Data from ChEMBL 36 via Core Engine